Current Trends in Biotechnology and Pharmacy
General Description

Abbreviation
Curr trends biotechnol pharm
ISSN(online)
2230-7303
ISSN(print)
0973-8916
Open Access Journal
Hybrid
Licensing
CC BY, CC BY-NC
Peer Review
Peer Review
Impact Factor
0+
Indices
Google Scholar, Pubmed, SCImago, Scopus, UGC-CARE List
Language
English

All journal details can be verified on https://clarivate.com/

Detailed Information
Aim & Scope

The Association of Biotechnology and Pharmacy (ABAP) will be useful to form a forum for scientists so that they can bring together to discuss and find scientific solutions to the problems of society. The annual meetings will help the members to share their knowledge and publish their research knowledge particularly by members and fellows of the Association and special care will be taken to provide an opportunity for young scientists. Besides this, the association is planned to organize symposia, seminars and workshops on current developments of Biotechnology and Pharmacy particularly on the subject of current scientific interest, and the proceedings of which will be published regularly. And in view of the vast development of science and to disseminate the problems in the publication of research work, an international journal of Current Trends in Biotechnology and Pharmacy has been started by ABAP.

Indices
Google Scholar, Pubmed, SCImago, Scopus, UGC-CARE List
Keywords

Share:

Facebook
Twitter
LinkedIn
WhatsApp
Email
Contact Journal

    Related Journals
    Current Trends in Biotechnology and Pharmacy
    ISSN(online)
    2230-7303
    ISSN(print)
    0973-8916
    The Association of Biotechnology and Pharmacy (ABAP) will be useful to form a forum for s […]
    Plant Biotechnology Journal
    ISSN(online)
    1467-7652
    ISSN(print)
    1467-7644
    Plant Biotechnology Journal is published monthly by Wiley-Blackwell in association with t […]
    Nature Biotechnology
    ISSN(online)
    1546-1696
    ISSN(print)
    1087-0156
    Nature Biotechnology is a monthly journal covering the science and business of biotechnol […]
    Select your currency